ICICI Prudential US Bluechip Equity Fund Direct Growth

ICICI Prudential US Bluechip Equity Fund Direct Growth is an equity fund. This fund was started on 2 January, 2013. The fund is managed by Ritesh Lunawat. The fund could potentially beat inflation in the long-run.

1. ICICI Prudential US Bluechip Equity Fund Direct Growth has ₹3228 Cr worth of assets under management (AUM) as on Nov 2024 and is more than category average.
2. The fund has an expense ratio 1.2.
   

ICICI Prudential US Bluechip Equity Fund Direct Growth has given a CAGR return of 16.77% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 15.99%, 13.59% and 16.04% respectively.

ICICI Prudential US Bluechip Equity Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Industrial, Consumer Defensive, Tech, Financial Services, Communication, Consumer Cyclical, Basic Materials, Energy. Its top holdings are Gilead Sciences Inc, The Walt Disney Co, Altria Group Inc, Bristol-Myers Squibb Co, Boeing Co

As it is a global - other mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 15%
For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefit
Dividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.

The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. ICICI Prudential US Bluechip Equity Fund Direct Growth has no lock in period.